High-throughput screening (HTS) enables rapid discovery but introduces assay, automation, and data challenges. This article ...

Discover how robust screening assays enhance data quality and reliability in high-throughput screening for drug discovery.

Metrion Biosciences ("Metrion"), the specialist preclinical contract research organization (CRO) and a global leader in ion channel services, today announced the launch of its validated, ...

The India cell-based assay market is poised for growth due to increased drug discovery activities, automation in high-throughput screening, and outsourcing to CROs. Opportunities exist in 3D cell ...

Recent advances in organoid technology have opened the possibility of revolutionizing basic research, drug discovery and development, and patient treatment. In drug discovery, organoids are a viable ...

Developing new pharmaceuticals is a complex and costly process that requires innovation and efficiency. High-throughput immunoassays (HTIs) are an emerging technology poised to accelerate the drug ...

Drug discovery can be a long and complex process. Medicines for neurodegenerative diseases like Alzheimer's disease are among the most expensive to develop, as animal model results have not proven to ...

Three-dimensional cancer cell models, like tumoroids and spheroids, closely mimic the structure and behavior of tumors, making them powerful tools in cancer research and drug development. However, ...

UVA Comprehensive Cancer Center scientists have identified a molecule that blocks the gene responsible for glioblastoma, raising hopes that the molecule could become a much-needed new treatment for ...

Metrion Biosciences, today announced the launch of its validated, high-throughput NaV1.9 screening assay to advance discovery and development of novel pain therapeutics. Validated drug discovery assay ...